Category Archives: Health

Majority of Indians Face Cholesterol Imbalance, Raising Heart Risk: Redcliffe Labs Study

Over 80% Indians Show Lipid Derangements and Cholesterol Imbalance, Heightening Heart Risk, Reveals Redcliffe Labs’ Study

India, September 29, 2025: A comprehensive nationwide study by Redcliffe Labs, one of India’s fastest-growing diagnostic service providers, has uncovered deeply concerning trends in lipid, cardiac, and diabetes health markers across the country. Despite the rising burden of lifestyle-related diseases, preventive health checks remain underutilized, resulting in missed opportunities for early intervention.

The study analyzed over 7 million tests conducted between FY24 and FY25 and paints a troubling picture of India’s heart health:

• More than 40% of individuals showed signs of diabetes derangement, including abnormal HbA1c, fasting, or random glucose levels — significantly increasing their cardiovascular risk.

• These issues were more prevalent in men, making them especially vulnerable to sudden cardiac events.

• Lipid derangements (cholesterol and triglyceride imbalances), a key cause of heart disease, affected over 70% in 2024, and this rose to over 80% in 2025 — indicating a sharp year-on-year increase.

Dr. Prashant Nag, Chief Operating Medical Officer at Redcliffe Labs, commented:
“Unhealthy eating habits and sedentary lifestyles are a major culprit. Processed foods are easily accessible and widely consumed, leading to a dangerous cycle of high cholesterol, clogged arteries, and increased cardiac emergencies.”

Surprisingly, the health crisis is most pronounced in metro cities like Delhi, Mumbai, Bengaluru, Pune, Noida, Ahmedabad, Kolkata, Ghaziabad, Patna, and Lucknow — where awareness and access to healthcare are relatively higher, but unhealthy lifestyle patterns persist.

The study also revealed:

• A rise in cardiac risk marker derangements from 60% in 2024 to 65% in 2025, with women showing higher abnormalities.

  • This suggests women may exhibit earlier signs of cardiac risk, offering a critical window for early intervention.

• Early onset of risk factors like high cholesterol and elevated blood sugar in young adults, including those under 20, especially in urban areas.

  • Diseases once associated with middle or older age are now appearing in younger, working-age populations.

Aditya Kandoi, CEO & Founder of Redcliffe Labs, said: “India cannot afford to sleepwalk into a cardiac epidemic. These aren’t just numbers — they’re indicators of a national health crisis. What’s even more concerning is that many people don’t get tested until it’s too late.”

To address this gap, Redcliffe Labs recently launched India’s Wake-Up Test, a bold initiative that offers a 100% refund if the test reports are 100% normal — encouraging healthy individuals to test without hesitation.

“If you’re healthy, you pay nothing — but if something is found, you gain the chance to act early,” Kandoi added.“Prevention is not an expense; it’s an investment in the nation’s future. We urge every Indian to prioritize regular health checks — for themselves, their families, and for a healthier India.”

Aster Medcity Performs Kerala’s First Non-Surgical Fontan for Single-Ventricle Heart

Aster Medcity Performs Kerala’s First Non- Surgical Fontan Procedure on Children with Single-Ventricle Heart

Kochi, 29th September 2025: Aster Medcity has achieved a major milestone in pediatric cardiology by successfully performing Kerala’s first-ever Transcatheter Fontan completions—a non-surgical alternative for children with complex congenital heart defects. The groundbreaking procedures were performed on two young children, offering them a less invasive path to improved heart function without the need for open-heart surgery.

The Fontan completion is the final and critical stage in the treatment of children born with single-ventricle physiology, a condition where only one heart chamber effectively pumps blood. Traditionally, this requires major surgery to connect the inferior vena cava (IVC) to the pulmonary artery, allowing oxygen-poor blood to reach the lungs without passing through the heart.

One of the first recipients was a five-year-old girl from Idukki, diagnosed with pulmonary atresia with intact ventricular septum, who had previously undergone a Glenn shunt in infancy. Her case was particularly complex due to her family’s Jehovah’s Witness faith, which prohibits blood transfusions, making traditional surgery too risky. The Aster team successfully completed the Fontan circulation using a covered stent, and she was discharged in five days. Two months later, she is thriving.

The second case involved a four-and-a-half-year-old boy from Ernakulam, born with a double inlet left ventricle. Having already undergone two surgeries, his family sought a minimally invasive alternative to avoid a third open-heart procedure. After careful planning and CT imaging, a covered stent was placed, completing the Fontan pathway. The child recovered quickly with no complications.

“This innovative approach offers new hope to families of children with complex heart defects, and we are proud to introduce this advanced, non-surgical treatment in Kerala,” said Dr. Edwin Francis, Director & Senior Consultant – Paediatric Cardiology, Aster Medcity, Kochi.

Both procedures represent a transformative shift in managing single-ventricle heart conditions—achieving Fontan circulation without major incisions, bypass, or blood transfusions.

Zydus and Pinkathon join hands to drive awareness on breast cancer across India

Zydus Lifesciences and Pinkathon Announce 10th Edition of Mumbai Pinkathon to Champion Women’s Health and Breast Cancer Awareness

Mumbai, September 25, 2025 —Zydus Lifesciences Ltd., a global innovation-driven healthcare company, in collaboration with Pinkathon, India’s largest women’s run, today announced the 10th edition of the Mumbai Pinkathon, to be held on 21st December 2025 at MMRDA Grounds, BKC. This marks the beginning of a six-city initiative across 2025–26 under the banner of Zydus Pinkathon, aimed at raising awareness on breast cancer and women’s health.

Uniting Fitness and Awareness

The announcement was made in the presence of:

• Dr. Sharvil Patel, Managing Director, Zydus Lifesciences Ltd.

• Meha Patel, Vice-Chairperson, Zydus Foundation

• Milind Soman, Actor, Fitness Icon & Founder of Pinkathon

• Ankita Konwar, Founder of Invincible Women

Together, they underlined the significance of regular self-breast exams and the role Zydus Pinkathon plays in encouraging early detection and proactive healthcare among women.

Dr. Sharvil Patel remarked,“With the Easiest Exam campaign, we want to empower women with the knowledge that a simple 3-minute self-exam each month can be life-saving. Through our partnership with Pinkathon, we aim to reach more women, raise awareness, and drive meaningful action in the fight against breast cancer.”

Milind Soman, Founder of Pinkathon, added,“Pinkathon has always championed women’s health, strength, and inclusivity. With Zydus as our Title Partner, we are taking this mission nationwide—encouraging every woman to prioritise her health and fitness.”

Meha Patel, Vice-Chairperson, Zydus Foundation, stated,“A woman’s wellbeing is central to the happiness of her family. Promoting regular self-breast exams is a small but vital step in addressing the alarming rise in breast cancer cases. As we say: ‘Swasth Nari, Sashakt Parivaar.’”

Event Details: Mumbai to Kick Off National Series

The Mumbai edition of Zydus Pinkathon will feature multiple run categories for varying fitness levels:

• 3 km, 5 km, and 10 km

• Ultra-distances of 50 km, 75 km, 100 km, and 100 km relay under the Invincible Women initiative

Registrations are now open across all categories.

Following Mumbai, Zydus Pinkathon will travel to Delhi, Bengaluru, Hyderabad, Kolkata, and Chennai, engaging over 30,000 women nationwide over the next nine months.

The Easiest Exam Campaign Returns in October

Coinciding with Breast Cancer Awareness Month, Zydus will launch the second edition of its impactful campaign — The Easiest Exam — encouraging women to perform a simple three-minute self-breast exam.

With the powerful message — “Do haath, teen minute aur ek easy exam” — the campaign will include:

• Nationwide awareness drives

• Podcasts and expert-led conversations

• Stories from breast cancer warriors

• On-ground community events

The goal: combat stigma, dispel myths, and empower women with life-saving knowledge.

Why It Matters

Breast cancer continues to be one of the most prevalent cancers among women in India. Over 2 lakh women are diagnosed every year, and tragically, a woman dies from breast cancer every 8 minutes—often due to late diagnosis. Early detection through regular self-checks can significantly improve survival rates.

Why Talking Openly About Prostate Health is Essential for Early Detection

India, 24th sept 2025: Prostate health is a crucial yet often overlooked aspect of men’s overall well-being. While conversations about breast cancer and women’s health have become more normalized in recent years, discussions surrounding prostate health, particularly prostate cancer, remain more taboo. This silence is not only detrimental to men’s health but also directly impacts the effectiveness of early detection and intervention.

The Importance of Prostate Health

The prostate is a small gland located below the bladder that plays a role in producing semen. As men age, their prostate undergoes various changes, some of which may lead to health problems. One of the most common issues affecting the prostate is prostate cancer, a condition that can be slow-growing and asymptomatic in its early stages.

According to the American Cancer Society, prostate cancer is the second most common cancer among men in the U.S. It’s estimated that 1 in 8 men will be diagnosed with prostate cancer during their lifetime. While the survival rates for prostate cancer are generally high, especially when detected early, many men remain unaware of their risks or delay seeking medical advice due to embarrassment, fear, or lack of awareness.

Breaking the Silence: The Role of Open Communication

1. Encouraging Early Detection

One of the biggest barriers to early detection of prostate issues is the reluctance to talk about prostate health. Many men, particularly those under the age of 50, may not think about their prostate until they experience symptoms, which often don’t appear until the condition has advanced.

Early detection through screenings like the PSA (Prostate-Specific Antigen) test or a digital rectal exam (DRE) can identify potential issues long before they develop into life-threatening conditions. However, for many men, the thought of discussing their prostate health with a doctor is daunting, and they may avoid necessary tests or consultations.

When men are encouraged to openly discuss prostate health with their healthcare providers, they’re more likely to undergo regular screenings, which can lead to earlier detection of problems like prostate cancer or benign prostatic hyperplasia (BPH), a non-cancerous enlargement of the prostate. Early detection is a game-changer, as it improves the chances of successful treatment and survival.

2. Reducing Stigma Around Prostate Health

A major reason why many men avoid conversations about their prostate is the stigma surrounding it. The topic of men’s sexual and reproductive health has long been shrouded in discomfort and taboo. Discussions about urination issues, erectile dysfunction, and sexual health are often seen as embarrassing or personal.

By talking openly about prostate health, men can help reduce the shame associated with these health concerns. Normalizing conversations about issues like frequent urination, difficulty starting or stopping urination, or blood in the urine can encourage others to seek medical help rather than suffer in silence. Over time, these open conversations can also lead to better-informed communities and reduce the anxiety men may feel when faced with prostate-related issues.

3. Empowering Men to Take Control of Their Health

Men often face societal pressures to be stoic, strong, and unaffected by illness. This cultural expectation can discourage many from seeking medical attention when needed, leading to delayed diagnoses and more severe health outcomes. Open discussions about prostate health can empower men to take charge of their health, encourage them to undergo preventive screenings, and foster a sense of agency in managing their well-being.

When men understand that regular checkups are not only for when they’re feeling sick but are also an essential part of maintaining their health, they’re more likely to prioritize prostate screenings as part of their routine healthcare.

The Benefits of Early Detection

The earlier prostate problems are detected, the easier they are to treat. Here are a few key benefits of early detection:

1. Better Survival Rates for Prostate Cancer: Prostate cancer often develops slowly, and when caught early, it has a high survival rate. In fact, nearly 99% of men diagnosed with localized prostate cancer survive for at least five years after their diagnosis. Early detection allows for less aggressive treatment options, reducing the risk of side effects like incontinence and erectile dysfunction.
2. Prevention of Complications: Prostate health problems that are left untreated can lead to complications such as urinary retention, kidney damage, or bladder infections. Detecting and addressing these issues early on can prevent the need for more complex treatments down the road.
3. Improved Quality of Life: When men address prostate issues early, they have a better chance of managing their symptoms and maintaining their quality of life. Timely intervention can help mitigate the impact of symptoms such as urinary difficulties or sexual dysfunction, which are common in prostate conditions.

Why Should Men Get Regular Prostate Screenings?

Prostate health screenings are especially important for men at higher risk, including those who:

• Are over the age of 50 (or 45 for those with a family history of prostate cancer).
• Have a family history of prostate cancer or other related cancers.
• Are of African descent, as studies show African-American men are at higher risk.
• Experience symptoms such as frequent urination, difficulty starting or stopping urination, blood in urine, or pain during urination.

The two most common prostate screenings are:

• PSA Test (Prostate-Specific Antigen): A blood test that measures the level of PSA, a substance produced by the prostate. High levels of PSA can indicate prostate cancer, although other conditions like BPH or prostatitis can cause elevated PSA levels.
• Digital Rectal Exam (DRE): In this exam, a doctor manually checks the prostate for abnormalities in size, shape, and texture. Although it’s not as commonly used today due to the availability of PSA testing, it can still help identify issues with the prostate.

Moving Forward: Men’s Health Advocacy

Healthcare providers, community leaders, and public health organizations must continue to promote open dialogue around prostate health. Campaigns that encourage men to talk openly about their health and seek early screenings can go a long way in addressing this often-neglected aspect of men’s well-being.

Conclusion

Open conversations about prostate health are essential for encouraging early detection, reducing stigma, and empowering men to take control of their health. Early screening and intervention can significantly improve the prognosis for prostate cancer and other prostate-related conditions, leading to better outcomes and a higher quality of life. By normalizing discussions about prostate health, we can foster a culture of awareness, prevention, and proactive care, ultimately ensuring that more men are informed, supported, and able to make decisions that benefit their long-term health.

The time has come for men to talk openly about prostate health—because when they do, they give themselves the best chance for a healthy future.

Dr Santosh G. Honavar Tops the Stanford List of Researchers in Ophthalmology for Career-long Impact

The rankings feature the top 2% of researchers worldwide

New Delhi/Hyderabad, Sept 23, 2025:.Dr. Santosh G. Honavar, Honorary Secretary of the All-India Ophthalmological Society (AIOS), Director of Ophthalmic Plastic Surgery and Ocular Oncology at Centre for Sight Eye Hospital, Hyderabad, former Associate Director of LV Prasad Eye Institute, Hyderabad, and the past Editor of the Indian Journal of Ophthalmology, has yet again emerged as the top-ranked Ophthalmology researcher from India.

For the fifth consecutive year, Dr Honavar has secured the number one position in the annual impact ranking and, for the first time, has also topped the career-long impact ranking in Ophthalmology from India. A panel of experts from Stanford University and Elsevier announced the prestigious lifetime and annual global rankings for 2025. The rankings feature the top 2% of researchers worldwide, based on the influence and impact of their work, both career-long and during the year 2024.

Dr Santosh G. Honavar is an internationally renowned ophthalmologist with expertise in eye cancers, and his illustrious career has earned him accolades such as the prestigious Shanti Swarup Bhatnagar Award from the Government of India and the Lifetime Achievement Award from the American Academy of Ophthalmology. He is the sole ophthalmologist from the Indian subcontinent to receive the Honorary Fellowship, the highest honour bestowed by the Royal College of Ophthalmologists in the UK. Dr Santosh G. Honavar also holds the second position in the Stanford List based on his lifelong contributions to the field. He has over 17000 citations and a high H-index of 69.

Dr. Partha Biswas, the President of AIOS, extended his congratulations to the Indian researchers featured in the Stanford list. He highlighted AIOS’s commitment to promoting Indian research through its Journals (Indian Journal of Ophthalmology and IJO Case Reports), scientific activities, and research as part of the Vision 2030 strategy, which aims to support and nurture the research potential of Indian ophthalmologists. He expressed optimism about witnessing more young Indian ophthalmologists making their mark on the Stanford list soon. The consistent rise in representation of Indian Ophthalmology in such prestigious global lists reflects the growing trajectory of high-quality research across the country and it underlines the strength of our institutions, the dedication of our researchers, and India’s emergence as a global leader in ophthalmology and vision sciences, Dr Biswas emphasised.

There are 27 Indian Ophthalmologists who are part of the list of the top 2% of researchers in the world in terms of career-long impact. Sixty-one Indian Ophthalmologists figure in the list of the top 2% of world researchers, considering the impact of their work in 2024. This year’s list includes eminent Ophthalmology researchers from across India, representing leading institutions such as LV Prasad Eye Institute, Hyderabad (17 researchers); Dr. Rajendra Prasad Centre for Ophthalmic Sciences, AIIMS, New Delhi (12); Sankara Nethralaya, Chennai (5); Aravind Eye Care System, Madurai (4); Narayana Nethralaya, Bengaluru (4); Dr. Agarwal’s Eye Hospital, Chennai (3); Centre for Sight, Hyderabad (2); and PGIMER, Chandigarh (2), among others.

The Top 10 in the Stanford 2025 list for career-long impact are: 1. Santosh G. Honavar, 2. Gullapalli N. Rao, 3. Philip Aloysius Thomas, 4. Virender S. Sangwan, 5. Savitri Sharma, 6. Muthiah K. Srinivasan, 7. D. Balasubramanian, 8. Amod Gupta, 9. GVS Murthy, and 10. Mohd Javed Ali

The top 10 Indian researchers in ophthalmology included in the 2025 Stanford list are: 1. Santosh G. Honavar, 2. Mohammad Javed Ali, 3. Swathi Kaliki, 4. GVS Murthy, 5. Savitri Sharma, 6. Namrata Sharma, 7. Vinod Kumar, 8. Philip Aloysius Thomas, 9. Virender S. Sangwan, and 10. Dr. Prashant Garg

All India Ophthalmological Society is the world’s second-largest professional organisation of Ophthalmologists, with over 26000 members.

National Nutrition Month: Cut Down on Sugar, Salt, and Oil, Experts Warn

Aster DM Healthcare joins the United Nations’ Race to Zero’ Campaign, Commits to Net Zero status by 2050

Kochi, September 23, 2025: Aster DM Healthcare, one of the largest integrated healthcare providers in India, is proud to announce its official membership in the United Nations’ ‘Race to Zero’ campaign, a global alliance committed to achieving net-zero carbon emissions by 2050.

As part of its Race to Zero campaign, Aster has successfully commissioned an 8.5 MW solar park in Kasargod, Kerala committing to sustainability and promotion of renewable energy usage.

As part of the Race to Zero commitment, Aster DM Healthcare has pledged to achieve Net Zero emissions across all its operations by 2050, aligning with the 1.5°C global warming target. To achieve this goal, Aster will reduce energy consumption, shift to renewable energy sources, and upgrade its infrastructure to meet high sustainability standards. The company will enhance waste management through strong reduction and recycling practices, improve water conservation via rainwater harvesting and wastewater treatment, and prioritize green procurement by sourcing eco-friendly products and materials. Aster will also invest in carbon accounting and energy monitoring technologies to track and accelerate its decarbonization efforts. Internal sustainability workshops, employee initiatives, and community awareness campaigns will also be rolled out as part of its broader climate action program.

Dr. Azad Moopen, Founder Chairman and Managing Director of Aster DM Healthcare, said, “At Aster, our mission to ‘care for all’ naturally extends to the planet as climate change directly impacts health. Our decision to join the Race to Zero campaign is driven by our core belief that healthcare must include nurturing the environment that sustains us all. By joining the campaign, we are taking a significant step towards embedding sustainability into our operations and setting a benchmark for responsible healthcare”.

The Race to Zero campaign, backed by the UN Climate Change High-Level Champions, brings together over 16,000 non-state actors across sectors worldwide, all committed to halving emissions by 2030 and achieving Net Zero by 2050.

Pushpanjali Medicon 2025 Concludes with 2,500+ Global Medical Experts in Attendance

New Delhi,18 september 2025 : Pushpanjali Medicon 2025, one of the most awaited gatherings in the field of healthcare excellence, concluded successfully today. The event brought together leading doctors, specialists, and healthcare professionals from across India and abroad, ranging more than 2500, establishing itself as a landmark academic and skill-building platform.

The event commenced on 6th September with an intensive ACLS-BLS workshop, where over 200 participants underwent hands-on training in advanced cardiac life support and basic life support. The workshop equipped doctors, nurses, and paramedics with critical lifesaving skills, with all participants receiving certifications upon successful completion, further enhancing their professional expertise.

On 7th September, Pushpanjali Medicon 2025 hosted its flagship scientific program, which drew an overwhelming participation of more than 2500 delegates. The day-long sessions featured thought-provoking presentations and panel discussions by eminent speakers from India and abroad, who shared insights on the latest advances in healthcare, innovative treatment protocols, and emerging trends in medicine. The scientific program not only reinforced academic rigor but also emphasized practical learning, making it a truly enriching experience for the medical fraternity.

Prominent medical luminaries such as Dr. Amitava Gupta, a leading hand surgeon from the USA, widely respected for his advancements in microsurgical reconstruction, Dr. Terrance Khastgir, a distinguished leader in the field of electrophysiology, known for his pioneering work in cardiac rhythm management, Dr. Shekhar Sheshadri, an acclaimed psychiatrist and mental health advocate, who emphasized the importance of holistic well-being alongside clinical excellence.

Dr. Randeep Guleria, renowned pulmonologist and former Director of AIIMS, Dr. Deepak Talwar, a pioneer in respiratory and critical care, and Dr. Vijay Aggarwal, an eminent voice in healthcare quality and policy, shared their expertise at the event. The conference also featured insights from Dr. R.V. Asokan, Dr. J.A. Jayalal, and Dr. Satyender Tyagi, their collective presence highlighted the academic depth and international stature of Pushpanjali Medicon 2025.

Reflecting on the success of the event, Dr. Vinay Aggarwal, Chief Patron of Pushpanjali Medicon 2025, said “Pushpanjali Medicon has always been a platform to celebrate excellence, share knowledge, and inspire the medical fraternity to reach greater heights. The overwhelming response to this year’s event is a testament to its growing impact, and I am confident it will contribute immensely to advancing healthcare and patient well-being.”

With its perfect blend of skill-based training and scientific exchange, Pushpanjali Medicon 2025 has once again reaffirmed its place as a milestone event in medical education and healthcare advancement.

16-Month-Old Baby Operated From 1,600 km Away!

Hyderabad, September 18, 2025: We are familiar with robotic surgery and have heard about telesurgery as well. But combining both to provide relief to patients in remote areas has now become a reality. Using India’s indigenously developed SSI Mantra robotic system, such telesurgeries were successfully performed. Dr. V. Chandramohan, Managing Director of Preeti Kidney Hospital and Chief Urologist, shared details of these remarkable achievements.

“A 16-month-old baby was born with a congenital kidney problem. The renal pelvis – a funnel-shaped part of the kidney that connects to the ureter – was blocked, a condition known as ureteropelvic obstruction. As a result, urine could not flow from the kidney to the bladder. The baby needed surgery to clear the obstruction. Since the child was only 16 months old, we decided to opt for robotic surgery. The baby was brought to Preeti Kidney Hospital, Kondapur, while I sat at the console in Gurugram at the SSI Mantra office, about 1,600 kilometers away. I performed the surgery remotely through the robot. It took just an hour, enabled by 5G technology and robotic systems. Earlier, a similar telesurgery had been reported in China for an 8-year-old. This makes our case the world’s youngest telesurgery ever performed on a 16-month-old child, who was discharged the very next day,” explained Dr. Chandramohan.

In another case, a woman in Moradabad, Uttar Pradesh, suffered from urinary leakage after a hysterectomy (removal of the uterus). She required advanced robotic surgery, but local surgeons there were only trained in open procedures. They reached out to Preeti Hospital, and through 5G connectivity and the SSI Mantra robotic system, Dr. Chandramohan performed the surgery remotely. The operation lasted an hour and 20 minutes, marking the first-ever cross-state telesurgery of its kind.

These surgeries were made possible with the support of the hospital’s Executive Director Dr. Roopa, CEO Dr. Rangappa, Senior Surgeon Dr. Ramakrishna, Senior Urologists Dr. Hemant and Dr. Soundarya, Pediatric Anesthetist Dr. Devender, Pediatrician Dr. Vamsi, coordinators Rajender, Ganesh, and Anil, Senior Technician Sridhar, robotic engineers Durgesh and Ishan Prashant, SSI Mantra Director Vishva, and SSI Mantra Robotics CEO Dr. Sudhir Srivastava, among others. The collective effort of this Indian team proved that distance is no barrier when technology and expertise come together.

“India is a vast country, and it is not possible to have top-level specialists in every corner. If groups of doctors invest in surgical robots, experts from major centers can operate remotely. A single console can connect with up to ten robots simultaneously. This not only helps patients but also serves as a learning tool for local doctors,” Dr. Chandramohan added.

Yashoda Medicity Advances Women’s Health with Cervical Cancer Awareness Session

An initiative to educate women on prevention, early detection, and care in support of the Hon’ble Prime Minister’s Swaasth Nari, Sashakt Parivar Abhiyaan

Ghaziabad, September 18, 2025: In support of the Hon’ble Prime Minister Shri Narendra Modi Ji’s Swaasth Nari, Sashakt Parivar Abhiyaan, launched on his 75th birthday to strengthen preventive healthcare for women, encourage early detection, and raise awareness about nutrition, menstrual hygiene, and mental wellbeing, Yashoda Medicity has launched a two-week long program dedicated to women’s health and family wellness.

To mark the beginning of this initiative, the Yashoda Institute of Cancer Care’s Women’s Cancer Center, in association with the Khora Makanpur Obstetrics & Gynaecological Society (KMOGS), organized an awareness session titled “Preventing Cervical Cancer: Scenarios to Solutions.”

The event was graced by Ms. Sunita Dayal, Hon’ble Mayor of Ghaziabad, who addressed the gathering on women’s journeys through cancer and the importance of timely screenings. The session featured leading oncologists and gynaecologists sharing perspectives on HPV vaccination, Pap smear testing, and solutions for improving awareness and access to care.

Dr. Upasana Arora, Managing Director, Yashoda Medicity, said, “Our vision is to create a healthcare ecosystem where prevention is as important as treatment. Cervical cancer is one of the most preventable forms of cancer if diagnosed early. Through such initiatives, we are working to spread awareness so that every woman has the chance to live a healthier, longer life.”

Ms. Sunita Dayal, Hon’ble Mayor of Ghaziabad, said, “On the occasion of our Hon’ble Prime Minister Shri Narendra Modi Ji’s birthday, it is inspiring to see the Yashoda Institute of Cancer Care’s Women’s Cancer Center lead efforts in women’s cancer care and preventive health. Such initiatives support healthier families and inclusive global growth.”

Dr. Satinder Kaur, Senior Director & Head of Gynecologic Oncology & Robotic Surgery, added, “Early detection is critical in saving lives. This programme encouraged women to prioritize their health and access screening services without hesitation.”

The two-week campaign will continue with health camps, free screenings, and awareness drives across specialties, reinforcing Yashoda Medicity’s commitment to advancing women’s health.